Anti-helminthic	B:C0003158
activity	O
of	O
Momordica	O
charantia	I:C0330482
L.	I:C0330482
against	O
Fasciola	O
hepatica	I:C3662687
eggs	I:C3662687
after	O
twelve	O
days	O
of	O
incubation	O
in	O
vitro	O
.	O

Anti-helminthic	O
activity	O
of	O
Momordica	B:C0330482
charantia	I:C0330482
L.	I:C0330482
against	O
Fasciola	O
hepatica	I:C3662687
eggs	I:C3662687
after	O
twelve	O
days	O
of	O
incubation	O
in	O
vitro	O
.	O

Anti-helminthic	O
activity	O
of	O
Momordica	O
charantia	I:C0330482
L.	I:C0330482
against	O
Fasciola	B:C3662687
hepatica	I:C3662687
eggs	I:C3662687
after	O
twelve	O
days	O
of	O
incubation	O
in	O
vitro	O
.	O

Anti-helminthic	O
activity	O
of	O
Momordica	O
charantia	I:C0330482
L.	I:C0330482
against	O
Fasciola	O
hepatica	I:C3662687
eggs	I:C3662687
after	O
twelve	O
days	O
of	O
incubation	B:C1439852
in	O
vitro	O
.	O

Fasciolosis	B:C0015652
,	O
a	O
parasitic	O
disease	I:C0030499
caused	O
by	O
the	O
trematode	O
Fasciola	O
hepatica	I:C0015648
underreported	O
is	O
expanding	O
both	O
in	O
human	O
and	O
animal	O
population	I:C1318101
,	O
throughout	O
the	O
world	O
.	O

Fasciolosis	O
,	O
a	O
parasitic	B:C0030499
disease	I:C0030499
caused	O
by	O
the	O
trematode	O
Fasciola	O
hepatica	I:C0015648
underreported	O
is	O
expanding	O
both	O
in	O
human	O
and	O
animal	O
population	I:C1318101
,	O
throughout	O
the	O
world	O
.	O

Fasciolosis	O
,	O
a	O
parasitic	O
disease	I:C0030499
caused	O
by	O
the	O
trematode	B:C0040818
Fasciola	O
hepatica	I:C0015648
underreported	O
is	O
expanding	O
both	O
in	O
human	O
and	O
animal	O
population	I:C1318101
,	O
throughout	O
the	O
world	O
.	O

Fasciolosis	O
,	O
a	O
parasitic	O
disease	I:C0030499
caused	O
by	O
the	O
trematode	O
Fasciola	B:C0015648
hepatica	I:C0015648
underreported	O
is	O
expanding	O
both	O
in	O
human	O
and	O
animal	O
population	I:C1318101
,	O
throughout	O
the	O
world	O
.	O

Fasciolosis	O
,	O
a	O
parasitic	O
disease	I:C0030499
caused	O
by	O
the	O
trematode	O
Fasciola	O
hepatica	I:C0015648
underreported	O
is	O
expanding	O
both	O
in	O
human	B:C0086418
and	O
animal	O
population	I:C1318101
,	O
throughout	O
the	O
world	O
.	O

Fasciolosis	O
,	O
a	O
parasitic	O
disease	I:C0030499
caused	O
by	O
the	O
trematode	O
Fasciola	O
hepatica	I:C0015648
underreported	O
is	O
expanding	O
both	O
in	O
human	O
and	O
animal	B:C1318101
population	I:C1318101
,	O
throughout	O
the	O
world	O
.	O

Fasciolosis	O
,	O
a	O
parasitic	O
disease	I:C0030499
caused	O
by	O
the	O
trematode	O
Fasciola	O
hepatica	I:C0015648
underreported	O
is	O
expanding	O
both	O
in	O
human	O
and	O
animal	O
population	I:C1318101
,	O
throughout	O
the	O
world	B:C2700280
.	O

The	O
constant	O
use	O
of	O
synthetic	B:C0259849
drugs	I:C0259849
to	O
treat	O
this	O
condition	O
has	O
led	O
to	O
the	O
natural	O
selection	O
of	O
resistant	O
strains	O
of	O
the	O
parasite	O
.	O

The	O
constant	O
use	O
of	O
synthetic	O
drugs	I:C0259849
to	O
treat	B:C0087111
this	O
condition	O
has	O
led	O
to	O
the	O
natural	O
selection	O
of	O
resistant	O
strains	O
of	O
the	O
parasite	O
.	O

The	O
constant	O
use	O
of	O
synthetic	O
drugs	I:C0259849
to	O
treat	O
this	O
condition	B:C0012634
has	O
led	O
to	O
the	O
natural	O
selection	O
of	O
resistant	O
strains	O
of	O
the	O
parasite	O
.	O

The	O
constant	O
use	O
of	O
synthetic	O
drugs	I:C0259849
to	O
treat	O
this	O
condition	O
has	O
led	O
to	O
the	O
natural	O
selection	O
of	O
resistant	O
strains	O
of	O
the	O
parasite	B:C0030498
.	O

Hence	O
,	O
there	O
is	O
a	O
growing	O
focus	O
on	O
the	O
potential	O
anti-helminthic	B:C0003158
properties	O
of	O
medicinal	O
plants	I:C0032100
and	O
phytopharmaceuticals	O
.	O

Hence	O
,	O
there	O
is	O
a	O
growing	O
focus	O
on	O
the	O
potential	O
anti-helminthic	O
properties	O
of	O
medicinal	B:C0032100
plants	I:C0032100
and	O
phytopharmaceuticals	O
.	O

Hence	O
,	O
there	O
is	O
a	O
growing	O
focus	O
on	O
the	O
potential	O
anti-helminthic	O
properties	O
of	O
medicinal	O
plants	I:C0032100
and	O
phytopharmaceuticals	B:C0577749
.	O

The	O
current	O
study	B:C2603343
assessed	O
the	O
potential	O
anti-fasciolicide	O
action	O
of	O
Momordica	O
charantia	I:C0330482
leaf	O
extracts	O
and	O
fractions	O
on	O
the	O
eggs	O
of	I:C3662687
F.	I:C3662687
hepatica	I:C3662687
parasites	I:C3662687
.	O

The	O
current	O
study	O
assessed	O
the	O
potential	O
anti-fasciolicide	O
action	O
of	O
Momordica	B:C0330482
charantia	I:C0330482
leaf	O
extracts	O
and	O
fractions	O
on	O
the	O
eggs	O
of	I:C3662687
F.	I:C3662687
hepatica	I:C3662687
parasites	I:C3662687
.	O

The	O
current	O
study	O
assessed	O
the	O
potential	O
anti-fasciolicide	O
action	O
of	O
Momordica	O
charantia	I:C0330482
leaf	B:C0242724
extracts	O
and	O
fractions	O
on	O
the	O
eggs	O
of	I:C3662687
F.	I:C3662687
hepatica	I:C3662687
parasites	I:C3662687
.	O

The	O
current	O
study	O
assessed	O
the	O
potential	O
anti-fasciolicide	O
action	O
of	O
Momordica	O
charantia	I:C0330482
leaf	O
extracts	B:C0032081
and	O
fractions	O
on	O
the	O
eggs	O
of	I:C3662687
F.	I:C3662687
hepatica	I:C3662687
parasites	I:C3662687
.	O

The	O
current	O
study	O
assessed	O
the	O
potential	O
anti-fasciolicide	O
action	O
of	O
Momordica	O
charantia	I:C0330482
leaf	O
extracts	O
and	O
fractions	O
on	O
the	O
eggs	B:C3662687
of	I:C3662687
F.	I:C3662687
hepatica	I:C3662687
parasites	I:C3662687
.	O

The	O
lyophilized	O
crude	B:C1258023
extract	I:C1258023
(	O
crude	O
extract	I:C1258023
)	O
of	O
M.	O
charantia	I:C0330482
leaves	I:C0330482
and	O
its	O
sub-fractions	O
,	O
obtained	O
from	O
liquid	O
-	I:C3178840
liquid	I:C3178840
partitioning	I:C3178840
with	O
organic	O
solvents	I:C0360100
,	O
were	O
analysed	O
by	O
High	O
Performance	I:C0008562
Liquid	I:C0008562
Chromatography	I:C0008562
(	O
High	O
Performance	I:C0008562
Liquid	I:C0008562
Chromatography	I:C0008562
)	O
,	O
suspended	O
in	O
1	O
%	O
DMSO	O
and	O
used	O
in	O
in	O
vitro	O
tests	O
.	O

The	O
lyophilized	O
crude	O
extract	I:C1258023
(	O
crude	B:C1258023
extract	I:C1258023
)	O
of	O
M.	O
charantia	I:C0330482
leaves	I:C0330482
and	O
its	O
sub-fractions	O
,	O
obtained	O
from	O
liquid	O
-	I:C3178840
liquid	I:C3178840
partitioning	I:C3178840
with	O
organic	O
solvents	I:C0360100
,	O
were	O
analysed	O
by	O
High	O
Performance	I:C0008562
Liquid	I:C0008562
Chromatography	I:C0008562
(	O
High	O
Performance	I:C0008562
Liquid	I:C0008562
Chromatography	I:C0008562
)	O
,	O
suspended	O
in	O
1	O
%	O
DMSO	O
and	O
used	O
in	O
in	O
vitro	O
tests	O
.	O

The	O
lyophilized	O
crude	O
extract	I:C1258023
(	O
crude	O
extract	I:C1258023
)	O
of	O
M.	B:C0330482
charantia	I:C0330482
leaves	I:C0330482
and	O
its	O
sub-fractions	O
,	O
obtained	O
from	O
liquid	O
-	I:C3178840
liquid	I:C3178840
partitioning	I:C3178840
with	O
organic	O
solvents	I:C0360100
,	O
were	O
analysed	O
by	O
High	O
Performance	I:C0008562
Liquid	I:C0008562
Chromatography	I:C0008562
(	O
High	O
Performance	I:C0008562
Liquid	I:C0008562
Chromatography	I:C0008562
)	O
,	O
suspended	O
in	O
1	O
%	O
DMSO	O
and	O
used	O
in	O
in	O
vitro	O
tests	O
.	O

The	O
lyophilized	O
crude	O
extract	I:C1258023
(	O
crude	O
extract	I:C1258023
)	O
of	O
M.	O
charantia	I:C0330482
leaves	I:C0330482
and	O
its	O
sub-fractions	O
,	O
obtained	O
from	O
liquid	B:C3178840
-	I:C3178840
liquid	I:C3178840
partitioning	I:C3178840
with	O
organic	O
solvents	I:C0360100
,	O
were	O
analysed	O
by	O
High	O
Performance	I:C0008562
Liquid	I:C0008562
Chromatography	I:C0008562
(	O
High	O
Performance	I:C0008562
Liquid	I:C0008562
Chromatography	I:C0008562
)	O
,	O
suspended	O
in	O
1	O
%	O
DMSO	O
and	O
used	O
in	O
in	O
vitro	O
tests	O
.	O

The	O
lyophilized	O
crude	O
extract	I:C1258023
(	O
crude	O
extract	I:C1258023
)	O
of	O
M.	O
charantia	I:C0330482
leaves	I:C0330482
and	O
its	O
sub-fractions	O
,	O
obtained	O
from	O
liquid	O
-	I:C3178840
liquid	I:C3178840
partitioning	I:C3178840
with	O
organic	B:C0360100
solvents	I:C0360100
,	O
were	O
analysed	O
by	O
High	O
Performance	I:C0008562
Liquid	I:C0008562
Chromatography	I:C0008562
(	O
High	O
Performance	I:C0008562
Liquid	I:C0008562
Chromatography	I:C0008562
)	O
,	O
suspended	O
in	O
1	O
%	O
DMSO	O
and	O
used	O
in	O
in	O
vitro	O
tests	O
.	O

The	O
lyophilized	O
crude	O
extract	I:C1258023
(	O
crude	O
extract	I:C1258023
)	O
of	O
M.	O
charantia	I:C0330482
leaves	I:C0330482
and	O
its	O
sub-fractions	O
,	O
obtained	O
from	O
liquid	O
-	I:C3178840
liquid	I:C3178840
partitioning	I:C3178840
with	O
organic	O
solvents	I:C0360100
,	O
were	O
analysed	B:C0936012
by	O
High	O
Performance	I:C0008562
Liquid	I:C0008562
Chromatography	I:C0008562
(	O
High	O
Performance	I:C0008562
Liquid	I:C0008562
Chromatography	I:C0008562
)	O
,	O
suspended	O
in	O
1	O
%	O
DMSO	O
and	O
used	O
in	O
in	O
vitro	O
tests	O
.	O

The	O
lyophilized	O
crude	O
extract	I:C1258023
(	O
crude	O
extract	I:C1258023
)	O
of	O
M.	O
charantia	I:C0330482
leaves	I:C0330482
and	O
its	O
sub-fractions	O
,	O
obtained	O
from	O
liquid	O
-	I:C3178840
liquid	I:C3178840
partitioning	I:C3178840
with	O
organic	O
solvents	I:C0360100
,	O
were	O
analysed	O
by	O
High	B:C0008562
Performance	I:C0008562
Liquid	I:C0008562
Chromatography	I:C0008562
(	O
High	O
Performance	I:C0008562
Liquid	I:C0008562
Chromatography	I:C0008562
)	O
,	O
suspended	O
in	O
1	O
%	O
DMSO	O
and	O
used	O
in	O
in	O
vitro	O
tests	O
.	O

The	O
lyophilized	O
crude	O
extract	I:C1258023
(	O
crude	O
extract	I:C1258023
)	O
of	O
M.	O
charantia	I:C0330482
leaves	I:C0330482
and	O
its	O
sub-fractions	O
,	O
obtained	O
from	O
liquid	O
-	I:C3178840
liquid	I:C3178840
partitioning	I:C3178840
with	O
organic	O
solvents	I:C0360100
,	O
were	O
analysed	O
by	O
High	O
Performance	I:C0008562
Liquid	I:C0008562
Chromatography	I:C0008562
(	O
High	B:C0008562
Performance	I:C0008562
Liquid	I:C0008562
Chromatography	I:C0008562
)	O
,	O
suspended	O
in	O
1	O
%	O
DMSO	O
and	O
used	O
in	O
in	O
vitro	O
tests	O
.	O

The	O
lyophilized	O
crude	O
extract	I:C1258023
(	O
crude	O
extract	I:C1258023
)	O
of	O
M.	O
charantia	I:C0330482
leaves	I:C0330482
and	O
its	O
sub-fractions	O
,	O
obtained	O
from	O
liquid	O
-	I:C3178840
liquid	I:C3178840
partitioning	I:C3178840
with	O
organic	O
solvents	I:C0360100
,	O
were	O
analysed	O
by	O
High	O
Performance	I:C0008562
Liquid	I:C0008562
Chromatography	I:C0008562
(	O
High	O
Performance	I:C0008562
Liquid	I:C0008562
Chromatography	I:C0008562
)	O
,	O
suspended	O
in	O
1	O
%	O
DMSO	B:C0012403
and	O
used	O
in	O
in	O
vitro	O
tests	O
.	O

The	O
lyophilized	O
crude	O
extract	I:C1258023
(	O
crude	O
extract	I:C1258023
)	O
of	O
M.	O
charantia	I:C0330482
leaves	I:C0330482
and	O
its	O
sub-fractions	O
,	O
obtained	O
from	O
liquid	O
-	I:C3178840
liquid	I:C3178840
partitioning	I:C3178840
with	O
organic	O
solvents	I:C0360100
,	O
were	O
analysed	O
by	O
High	O
Performance	I:C0008562
Liquid	I:C0008562
Chromatography	I:C0008562
(	O
High	O
Performance	I:C0008562
Liquid	I:C0008562
Chromatography	I:C0008562
)	O
,	O
suspended	O
in	O
1	O
%	O
DMSO	O
and	O
used	O
in	O
in	O
vitro	O
tests	B:C0022885
.	O

Quadruplicates	O
of	O
50	O
F.	B:C3662687
hepatica	I:C3662687
eggs	I:C3662687
were	O
incubated	O
at	O
23	O
°C	O
with	O
M.	O
charantia	I:C0330482
leaf	O
crude	O
extract	I:C1258023
in	O
different	O
concentrations	O
.	O

Quadruplicates	O
of	O
50	O
F.	O
hepatica	I:C3662687
eggs	I:C3662687
were	O
incubated	B:C1439852
at	O
23	O
°C	O
with	O
M.	O
charantia	I:C0330482
leaf	O
crude	O
extract	I:C1258023
in	O
different	O
concentrations	O
.	O

Quadruplicates	O
of	O
50	O
F.	O
hepatica	I:C3662687
eggs	I:C3662687
were	O
incubated	O
at	O
23	O
°C	O
with	O
M.	B:C0330482
charantia	I:C0330482
leaf	O
crude	O
extract	I:C1258023
in	O
different	O
concentrations	O
.	O

Quadruplicates	O
of	O
50	O
F.	O
hepatica	I:C3662687
eggs	I:C3662687
were	O
incubated	O
at	O
23	O
°C	O
with	O
M.	O
charantia	I:C0330482
leaf	B:C0242724
crude	O
extract	I:C1258023
in	O
different	O
concentrations	O
.	O

Quadruplicates	O
of	O
50	O
F.	O
hepatica	I:C3662687
eggs	I:C3662687
were	O
incubated	O
at	O
23	O
°C	O
with	O
M.	O
charantia	I:C0330482
leaf	O
crude	B:C1258023
extract	I:C1258023
in	O
different	O
concentrations	O
.	O

After	O
12	O
days	O
no	O
larvae	B:C0023047
were	O
formed	O
in	O
eggs	O
incubated	O
with	O
crude	O
extract	I:C1258023
concentrations	O
above	O
12.5	O
mg	O
/	O
mL	O
.	O

After	O
12	O
days	O
no	O
larvae	O
were	O
formed	O
in	O
eggs	B:C3662687
incubated	O
with	O
crude	O
extract	I:C1258023
concentrations	O
above	O
12.5	O
mg	O
/	O
mL	O
.	O

After	O
12	O
days	O
no	O
larvae	O
were	O
formed	O
in	O
eggs	O
incubated	B:C1439852
with	O
crude	O
extract	I:C1258023
concentrations	O
above	O
12.5	O
mg	O
/	O
mL	O
.	O

After	O
12	O
days	O
no	O
larvae	O
were	O
formed	O
in	O
eggs	O
incubated	O
with	O
crude	B:C1258023
extract	I:C1258023
concentrations	O
above	O
12.5	O
mg	O
/	O
mL	O
.	O

Eggs	B:C3662687
incubated	O
with	O
crude	O
extract	I:C1258023
sub-fractions	O
at	O
concentrations	O
of	O
1000	O
,	O
100	O
,	O
10	O
,	O
1	O
,	O
0.1	O
,	O
0.01μg	O
/	O
mL	O
affected	O
embryonic	O
development	I:C0013936
,	O
with	O
n-butanol	O
presenting	O
the	O
strongest	O
inhibition	O
of	O
miracidia	O
formation	O
.	O

Eggs	O
incubated	B:C1439852
with	O
crude	O
extract	I:C1258023
sub-fractions	O
at	O
concentrations	O
of	O
1000	O
,	O
100	O
,	O
10	O
,	O
1	O
,	O
0.1	O
,	O
0.01μg	O
/	O
mL	O
affected	O
embryonic	O
development	I:C0013936
,	O
with	O
n-butanol	O
presenting	O
the	O
strongest	O
inhibition	O
of	O
miracidia	O
formation	O
.	O

Eggs	O
incubated	O
with	O
crude	B:C1258023
extract	I:C1258023
sub-fractions	O
at	O
concentrations	O
of	O
1000	O
,	O
100	O
,	O
10	O
,	O
1	O
,	O
0.1	O
,	O
0.01μg	O
/	O
mL	O
affected	O
embryonic	O
development	I:C0013936
,	O
with	O
n-butanol	O
presenting	O
the	O
strongest	O
inhibition	O
of	O
miracidia	O
formation	O
.	O

Eggs	O
incubated	O
with	O
crude	O
extract	I:C1258023
sub-fractions	O
at	O
concentrations	O
of	O
1000	O
,	O
100	O
,	O
10	O
,	O
1	O
,	O
0.1	O
,	O
0.01μg	O
/	O
mL	O
affected	O
embryonic	B:C0013936
development	I:C0013936
,	O
with	O
n-butanol	O
presenting	O
the	O
strongest	O
inhibition	O
of	O
miracidia	O
formation	O
.	O

Eggs	O
incubated	O
with	O
crude	O
extract	I:C1258023
sub-fractions	O
at	O
concentrations	O
of	O
1000	O
,	O
100	O
,	O
10	O
,	O
1	O
,	O
0.1	O
,	O
0.01μg	O
/	O
mL	O
affected	O
embryonic	O
development	I:C0013936
,	O
with	O
n-butanol	B:C0089147
presenting	O
the	O
strongest	O
inhibition	O
of	O
miracidia	O
formation	O
.	O

Eggs	O
incubated	O
with	O
crude	O
extract	I:C1258023
sub-fractions	O
at	O
concentrations	O
of	O
1000	O
,	O
100	O
,	O
10	O
,	O
1	O
,	O
0.1	O
,	O
0.01μg	O
/	O
mL	O
affected	O
embryonic	O
development	I:C0013936
,	O
with	O
n-butanol	O
presenting	O
the	O
strongest	O
inhibition	O
of	O
miracidia	B:C0023047
formation	O
.	O

In	O
contrast	O
,	O
on	O
the	O
12th	O
day	O
,	O
90	O
%	O
of	O
the	O
miracidia	B:C0023047
hatched	O
in	O
the	O
control	O
experiments	O
using	O
0.03	O
%	O
DMSO	O
whereas	O
embryogenesis	O
was	O
completely	O
abolished	O
with	O
any	O
concentration	O
of	O
albendazole	O
sulphoxide	I:C0051091
ABZ	O
(	I:C0051091
SO	I:C0051091
)	I:C0051091
.	O

In	O
contrast	O
,	O
on	O
the	O
12th	O
day	O
,	O
90	O
%	O
of	O
the	O
miracidia	O
hatched	B:C0598016
in	O
the	O
control	O
experiments	O
using	O
0.03	O
%	O
DMSO	O
whereas	O
embryogenesis	O
was	O
completely	O
abolished	O
with	O
any	O
concentration	O
of	O
albendazole	O
sulphoxide	I:C0051091
ABZ	O
(	I:C0051091
SO	I:C0051091
)	I:C0051091
.	O

In	O
contrast	O
,	O
on	O
the	O
12th	O
day	O
,	O
90	O
%	O
of	O
the	O
miracidia	O
hatched	O
in	O
the	O
control	O
experiments	O
using	O
0.03	O
%	O
DMSO	B:C0012403
whereas	O
embryogenesis	O
was	O
completely	O
abolished	O
with	O
any	O
concentration	O
of	O
albendazole	O
sulphoxide	I:C0051091
ABZ	O
(	I:C0051091
SO	I:C0051091
)	I:C0051091
.	O

In	O
contrast	O
,	O
on	O
the	O
12th	O
day	O
,	O
90	O
%	O
of	O
the	O
miracidia	O
hatched	O
in	O
the	O
control	O
experiments	O
using	O
0.03	O
%	O
DMSO	O
whereas	O
embryogenesis	B:C0013936
was	O
completely	O
abolished	O
with	O
any	O
concentration	O
of	O
albendazole	O
sulphoxide	I:C0051091
ABZ	O
(	I:C0051091
SO	I:C0051091
)	I:C0051091
.	O

In	O
contrast	O
,	O
on	O
the	O
12th	O
day	O
,	O
90	O
%	O
of	O
the	O
miracidia	O
hatched	O
in	O
the	O
control	O
experiments	O
using	O
0.03	O
%	O
DMSO	O
whereas	O
embryogenesis	O
was	O
completely	O
abolished	O
with	O
any	O
concentration	O
of	O
albendazole	B:C0051091
sulphoxide	I:C0051091
ABZ	O
(	I:C0051091
SO	I:C0051091
)	I:C0051091
.	O

In	O
contrast	O
,	O
on	O
the	O
12th	O
day	O
,	O
90	O
%	O
of	O
the	O
miracidia	O
hatched	O
in	O
the	O
control	O
experiments	O
using	O
0.03	O
%	O
DMSO	O
whereas	O
embryogenesis	O
was	O
completely	O
abolished	O
with	O
any	O
concentration	O
of	O
albendazole	O
sulphoxide	I:C0051091
ABZ	B:C0051091
(	I:C0051091
SO	I:C0051091
)	I:C0051091
.	O

Chemical	B:C3495389
analysis	I:C3495389
of	O
the	O
crude	O
extract	I:C1258023
and	O
sub-fractions	O
revealed	O
a	O
prominent	O
presence	O
of	O
flavonoids	O
.	O

Chemical	O
analysis	I:C3495389
of	O
the	O
crude	B:C1258023
extract	I:C1258023
and	O
sub-fractions	O
revealed	O
a	O
prominent	O
presence	O
of	O
flavonoids	O
.	O

Chemical	O
analysis	I:C3495389
of	O
the	O
crude	O
extract	I:C1258023
and	O
sub-fractions	O
revealed	O
a	O
prominent	O
presence	O
of	O
flavonoids	B:C0596577
.	O

HPLC	B:C3641325
-	I:C3641325
MS	I:C3641325
confirmed	O
Quercetin	O
to	O
be	O
one	O
of	O
the	O
main	O
flavonoids	O
present	O
in	O
the	O
crude	O
extract	I:C1258023
and	O
the	O
n-butanol	O
subfraction	O
.	O

HPLC	O
-	I:C3641325
MS	I:C3641325
confirmed	O
Quercetin	B:C0034392
to	O
be	O
one	O
of	O
the	O
main	O
flavonoids	O
present	O
in	O
the	O
crude	O
extract	I:C1258023
and	O
the	O
n-butanol	O
subfraction	O
.	O

HPLC	O
-	I:C3641325
MS	I:C3641325
confirmed	O
Quercetin	O
to	O
be	O
one	O
of	O
the	O
main	O
flavonoids	B:C0596577
present	O
in	O
the	O
crude	O
extract	I:C1258023
and	O
the	O
n-butanol	O
subfraction	O
.	O

HPLC	O
-	I:C3641325
MS	I:C3641325
confirmed	O
Quercetin	O
to	O
be	O
one	O
of	O
the	O
main	O
flavonoids	O
present	O
in	O
the	O
crude	B:C1258023
extract	I:C1258023
and	O
the	O
n-butanol	O
subfraction	O
.	O

HPLC	O
-	I:C3641325
MS	I:C3641325
confirmed	O
Quercetin	O
to	O
be	O
one	O
of	O
the	O
main	O
flavonoids	O
present	O
in	O
the	O
crude	O
extract	I:C1258023
and	O
the	O
n-butanol	B:C0089147
subfraction	O
.	O

This	O
is	O
the	O
first	O
study	B:C2603343
to	O
analyse	O
the	O
potential	O
anti-fasciolicide	O
action	O
of	O
M.	O
charantia	I:C0330482
leaf	O
crude	O
extract	I:C1258023
and	O
subfractions	O
.	O

This	O
is	O
the	O
first	O
study	O
to	O
analyse	B:C0936012
the	O
potential	O
anti-fasciolicide	O
action	O
of	O
M.	O
charantia	I:C0330482
leaf	O
crude	O
extract	I:C1258023
and	O
subfractions	O
.	O

This	O
is	O
the	O
first	O
study	O
to	O
analyse	O
the	O
potential	O
anti-fasciolicide	O
action	O
of	O
M.	B:C0330482
charantia	I:C0330482
leaf	O
crude	O
extract	I:C1258023
and	O
subfractions	O
.	O

This	O
is	O
the	O
first	O
study	O
to	O
analyse	O
the	O
potential	O
anti-fasciolicide	O
action	O
of	O
M.	O
charantia	I:C0330482
leaf	B:C0242724
crude	O
extract	I:C1258023
and	O
subfractions	O
.	O

This	O
is	O
the	O
first	O
study	O
to	O
analyse	O
the	O
potential	O
anti-fasciolicide	O
action	O
of	O
M.	O
charantia	I:C0330482
leaf	O
crude	B:C1258023
extract	I:C1258023
and	O
subfractions	O
.	O

